Key figures full-year 2025

Net sales in CHFm

269.3

EMEA was the best performing region and largest sales contributor.

Organic sales growth

15.7%

Driven by double-digit growth in all regions and all segments.

 

Core EBITDA margin

18.4%

Up 0.6 PP (CER) driven by cost discipline and volume leverage.

Events

Sep 22 Sep 22

Non-deal roadshow

Sep 22 Sep 22

UBS Best of Switzerland Conference

Sep 23 Sep 23

Investor trip, Barclays

Sep 24 Sep 24

UBS Best of Switzerland Conference

Nov 05 Nov 05

ZKB Swiss Equities Conference

Nov 09 Nov 09

Non-deal roadshow

Nov 10 Nov 10

Stifel Healthcare conference

Nov 11 Nov 11

Non-deal roadshow

Share information

Subscribe to ad hoc-News

Would you like to be informed about Medartis at first hand? Register and receive our news in electronic form.

Analyst Coverage


Research Partners AG 
Eugen Perger 
+41 44 533 40 30 
eugen.perger@researchpartners.ch


Stifel Nicolaus Europe Ltd.
Edward Hall
+44 7584 240 168
ed.hall@stifel.com


Zürcher Kantonalbank (ZKB) 
Michelle Büchler / Daniel Jelovcan 
+41 44 292 89 46 
michelle.buechler@zkb.ch


UBS
Tanya Hansalik / Leonie Zirn
+41-44-239-2053
tanya.hansalik@ubs.com

Do you have any more questions?

Fabian Hildbrand

Investor Relations:
investor.relations@medartis.com
Phone: +41 61 633 37 36
Phone: +41 61 633 37 34

Postal Address:
Medartis AG
Hochbergerstrasse 60E
CH-4057 Basel
Switzerland

×

Start your journey here